1. Home
  2. ACOG vs NRO Comparison

ACOG vs NRO Comparison

Compare ACOG & NRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

N/A

Current Price

$8.57

Market Cap

193.6M

Sector

N/A

ML Signal

N/A

Logo Neuberger Berman Real Estate Securities Income Fund Inc.

NRO

Neuberger Berman Real Estate Securities Income Fund Inc.

N/A

Current Price

$2.76

Market Cap

186.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ACOG
NRO
Founded
2000
N/A
Country
Canada
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
193.6M
186.3M
IPO Year
2024
2003

Fundamental Metrics

Financial Performance
Metric
ACOG
NRO
Price
$8.57
$2.76
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$16.00
N/A
AVG Volume (30 Days)
141.3K
170.4K
Earning Date
05-14-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
41.58
N/A
EPS
N/A
N/A
Revenue
$10,220,275.00
N/A
Revenue This Year
$139.22
N/A
Revenue Next Year
$134.48
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.50
$2.74
52 Week High
$10.14
$3.29

Technical Indicators

Market Signals
Indicator
ACOG
NRO
Relative Strength Index (RSI) 46.18 25.97
Support Level $7.50 N/A
Resistance Level $9.04 $3.07
Average True Range (ATR) 0.52 0.04
MACD -0.12 -0.02
Stochastic Oscillator 27.54 0.00

Price Performance

Historical Comparison
ACOG
NRO

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

About NRO Neuberger Berman Real Estate Securities Income Fund Inc.

NEUBERGER BERMAN REAL ESTATE SECURITIES INCOME FUND INC is a closed-end management investment company that invests mainly in securities issued by real estate companies, including real estate investment trusts (REITs). Its primary objective is to gain high current income with capital appreciation being the second. Under normal market conditions, the Fund invests at least 90% of its total assets in income-producing common equity securities, preferred securities, convertible securities and non-convertible debt securities issued by real estate companies, including real estate investment trusts ("REITs").

Share on Social Networks: